CVS Health Corporation (0HRS.L)
USD 67.18
(-5.26%)
USD 67.18
(-5.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 71.18 Billion USD | 23.19% |
| 2022 | 57.78 Billion USD | -13.22% |
| 2021 | 66.59 Billion USD | -13.73% |
| 2020 | 77.18 Billion USD | -7.36% |
| 2019 | 83.31 Billion USD | 20.11% |
| 2018 | 69.37 Billion USD | 174.12% |
| 2017 | 25.3 Billion USD | 4.74% |
| 2016 | 24.16 Billion USD | -3.38% |
| 2015 | 25 Billion USD | 138.73% |
| 2014 | 10.47 Billion USD | 12.47% |
| 2013 | 9.31 Billion USD | 10.17% |
| 2012 | 8.45 Billion USD | -1.72% |
| 2011 | 8.6 Billion USD | -0.34% |
| 2010 | 8.63 Billion USD | -14.46% |
| 2009 | 10.08 Billion USD | -3.01% |
| 2008 | 10.4 Billion USD | 10.36% |
| 2007 | 9.42 Billion USD | 108.22% |
| 2006 | 4.52 Billion USD | 170.14% |
| 2005 | 1.67 Billion USD | -31.6% |
| 2004 | 2.44 Billion USD | 950.97% |
| 2003 | 233.1 Million USD | -43.52% |
| 2002 | 412.7 Million USD | -50.65% |
| 2001 | 836.3 Million USD | 3.16% |
| 2000 | 810.7 Million USD | 1.74% |
| 1999 | 796.8 Million USD | -9.52% |
| 1998 | 880.6 Million USD | 54.36% |
| 1997 | 570.5 Million USD | 574.63% |
| 1996 | -120.2 Million USD | -148.06% |
| 1995 | 250.1 Million USD | -39.63% |
| 1994 | 414.3 Million USD | 18.1% |
| 1993 | 350.8 Million USD | 34.41% |
| 1992 | 261 Million USD | -34.44% |
| 1991 | 398.1 Million USD | 23.48% |
| 1990 | 322.4 Million USD | 1031.23% |
| 1989 | 28.5 Million USD | 111.91% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 71.99 Billion USD | 1.13% |
| 2024 Q2 | 71.26 Billion USD | -0.94% |
| 2023 Q4 | 71.18 Billion USD | 6.17% |
| 2023 FY | 71.18 Billion USD | 23.19% |
| 2023 Q1 | 61.86 Billion USD | 7.05% |
| 2023 Q2 | 68.32 Billion USD | 10.46% |
| 2023 Q3 | 67.05 Billion USD | -1.87% |
| 2022 Q1 | 67.47 Billion USD | 1.32% |
| 2022 Q2 | 62.05 Billion USD | -8.03% |
| 2022 Q3 | 53.87 Billion USD | -13.18% |
| 2022 Q4 | 57.78 Billion USD | 7.26% |
| 2022 FY | 57.78 Billion USD | -13.22% |
| 2021 Q3 | 68.83 Billion USD | -5.11% |
| 2021 Q4 | 66.59 Billion USD | -3.26% |
| 2021 FY | 66.59 Billion USD | -13.73% |
| 2021 Q1 | 76.71 Billion USD | -0.61% |
| 2021 Q2 | 72.53 Billion USD | -5.45% |
| 2020 Q3 | 78.01 Billion USD | 1.08% |
| 2020 FY | 77.18 Billion USD | -7.36% |
| 2020 Q1 | 82.23 Billion USD | -1.3% |
| 2020 Q2 | 77.18 Billion USD | -6.15% |
| 2020 Q4 | 77.18 Billion USD | -1.06% |
| 2019 Q1 | 89.65 Billion USD | 29.24% |
| 2019 Q3 | 84.48 Billion USD | -1.6% |
| 2019 Q2 | 85.86 Billion USD | -4.23% |
| 2019 Q4 | 83.31 Billion USD | -1.38% |
| 2019 FY | 83.31 Billion USD | 20.11% |
| 2018 FY | 69.37 Billion USD | 174.12% |
| 2018 Q4 | 69.37 Billion USD | 225.7% |
| 2018 Q3 | 21.29 Billion USD | 0.02% |
| 2018 Q2 | 21.29 Billion USD | -7.7% |
| 2018 Q1 | 23.07 Billion USD | -8.83% |
| 2017 Q4 | 25.3 Billion USD | 8.59% |
| 2017 FY | 25.3 Billion USD | 4.74% |
| 2017 Q3 | 23.3 Billion USD | -5.54% |
| 2017 Q2 | 24.67 Billion USD | -2.17% |
| 2017 Q1 | 25.21 Billion USD | 4.37% |
| 2016 Q2 | 27.5 Billion USD | 7.08% |
| 2016 Q1 | 25.69 Billion USD | 2.74% |
| 2016 FY | 24.16 Billion USD | -3.38% |
| 2016 Q3 | 24.54 Billion USD | -10.78% |
| 2016 Q4 | 24.16 Billion USD | -1.56% |
| 2015 Q1 | 11.24 Billion USD | 7.35% |
| 2015 FY | 25 Billion USD | 138.73% |
| 2015 Q4 | 25 Billion USD | 2.77% |
| 2015 Q3 | 24.33 Billion USD | 104.45% |
| 2015 Q2 | 11.9 Billion USD | 5.84% |
| 2014 Q1 | 10.64 Billion USD | 14.29% |
| 2014 Q3 | 11.92 Billion USD | 1.4% |
| 2014 Q4 | 10.47 Billion USD | -12.16% |
| 2014 FY | 10.47 Billion USD | 12.47% |
| 2014 Q2 | 11.75 Billion USD | 10.48% |
| 2013 Q1 | 8.11 Billion USD | -4.02% |
| 2013 FY | 9.31 Billion USD | 10.17% |
| 2013 Q4 | 9.31 Billion USD | 7.05% |
| 2013 Q3 | 8.7 Billion USD | 6.07% |
| 2013 Q2 | 8.2 Billion USD | 1.1% |
| 2012 Q1 | 7 Billion USD | -18.61% |
| 2012 FY | 8.45 Billion USD | -1.72% |
| 2012 Q4 | 8.45 Billion USD | -4.02% |
| 2012 Q3 | 8.8 Billion USD | 16.03% |
| 2012 Q2 | 7.59 Billion USD | 8.43% |
| 2011 Q2 | 8.85 Billion USD | 16.33% |
| 2011 FY | 8.6 Billion USD | -0.34% |
| 2011 Q3 | 9.06 Billion USD | 2.31% |
| 2011 Q4 | 8.6 Billion USD | -5.08% |
| 2011 Q1 | 7.61 Billion USD | -11.78% |
| 2010 Q1 | 10.32 Billion USD | 2.35% |
| 2010 FY | 8.63 Billion USD | -14.46% |
| 2010 Q4 | 8.63 Billion USD | -15.08% |
| 2010 Q3 | 10.16 Billion USD | -6.38% |
| 2010 Q2 | 10.85 Billion USD | 5.11% |
| 2009 Q1 | 10.13 Billion USD | -2.61% |
| 2009 Q3 | 10.82 Billion USD | 10.38% |
| 2009 Q4 | 10.08 Billion USD | -6.84% |
| 2009 Q2 | 9.81 Billion USD | -3.15% |
| 2009 FY | 10.08 Billion USD | -3.01% |
| 2008 Q3 | 8.44 Billion USD | -3.6% |
| 2008 FY | 10.4 Billion USD | 10.36% |
| 2008 Q1 | 8.92 Billion USD | -5.36% |
| 2008 Q2 | 8.75 Billion USD | -1.79% |
| 2008 Q4 | 10.4 Billion USD | 23.18% |
| 2007 Q4 | 9.42 Billion USD | 11.77% |
| 2007 Q3 | 8.43 Billion USD | -1.76% |
| 2007 Q1 | 6.1 Billion USD | 34.76% |
| 2007 FY | 9.42 Billion USD | 108.22% |
| 2007 Q2 | 8.58 Billion USD | 40.72% |
| 2006 FY | 4.52 Billion USD | 170.14% |
| 2006 Q2 | 5.75 Billion USD | 227.47% |
| 2006 Q1 | 1.75 Billion USD | 4.92% |
| 2006 Q3 | 6.09 Billion USD | 5.81% |
| 2006 Q4 | 4.52 Billion USD | -25.69% |
| 2005 Q3 | 2.42 Billion USD | -0.26% |
| 2005 Q4 | 1.67 Billion USD | -30.83% |
| 2005 Q1 | 2.64 Billion USD | 8.09% |
| 2005 FY | 1.67 Billion USD | -31.6% |
| 2005 Q2 | 2.42 Billion USD | -8.28% |
| 2004 Q1 | 124.5 Million USD | -46.59% |
| 2004 FY | 2.44 Billion USD | 950.97% |
| 2004 Q2 | 152.9 Million USD | 22.81% |
| 2004 Q3 | 2.57 Billion USD | 1585.87% |
| 2004 Q4 | 2.44 Billion USD | -4.96% |
| 2003 FY | 233.1 Million USD | -43.52% |
| 2003 Q2 | 541.2 Million USD | 17.63% |
| 2003 Q3 | 380.4 Million USD | -29.71% |
| 2003 Q4 | 233.1 Million USD | -38.72% |
| 2003 Q1 | 460.1 Million USD | 11.49% |
| 2002 Q4 | 412.7 Million USD | -46.74% |
| 2002 Q3 | 774.9 Million USD | -21.67% |
| 2002 Q2 | 989.3 Million USD | -5.59% |
| 2002 Q1 | 1.04 Billion USD | 25.3% |
| 2002 FY | 412.7 Million USD | -50.65% |
| 2001 Q3 | 1.05 Billion USD | -0.86% |
| 2001 Q2 | 1.06 Billion USD | -4.0% |
| 2001 Q1 | 1.1 Billion USD | 36.67% |
| 2001 FY | 836.3 Million USD | 3.16% |
| 2001 Q4 | 836.3 Million USD | -20.7% |
| 2000 FY | 810.7 Million USD | 1.74% |
| 2000 Q2 | 1.36 Billion USD | 8.08% |
| 2000 Q3 | 1.26 Billion USD | -7.42% |
| 2000 Q4 | 810.7 Million USD | -35.79% |
| 2000 Q1 | 1.26 Billion USD | 58.35% |
| 1999 Q1 | 975.7 Million USD | 10.8% |
| 1999 Q3 | 1.01 Billion USD | -4.94% |
| 1999 Q4 | 796.8 Million USD | -21.36% |
| 1999 Q2 | 1.06 Billion USD | 9.24% |
| 1999 FY | 796.8 Million USD | -9.52% |
| 1998 Q1 | 823.5 Million USD | 44.35% |
| 1998 Q3 | 864 Million USD | -4.03% |
| 1998 Q4 | 880.6 Million USD | 1.92% |
| 1998 FY | 880.6 Million USD | 54.36% |
| 1998 Q2 | 900.3 Million USD | 9.33% |
| 1997 Q1 | -40.6 Million USD | 66.22% |
| 1997 Q2 | 516.8 Million USD | 1372.91% |
| 1997 FY | 570.5 Million USD | 574.63% |
| 1997 Q4 | 570.5 Million USD | 253.69% |
| 1997 Q3 | 161.3 Million USD | -68.79% |
| 1996 Q3 | 235.8 Million USD | -28.76% |
| 1996 FY | -120.2 Million USD | -148.06% |
| 1996 Q1 | 737.5 Million USD | 194.88% |
| 1996 Q2 | 331 Million USD | -55.12% |
| 1996 Q4 | -120.2 Million USD | -150.98% |
| 1995 FY | 250.1 Million USD | -39.63% |
| 1995 Q4 | 250.1 Million USD | -79.02% |
| 1995 Q3 | 1.19 Billion USD | 13.15% |
| 1995 Q2 | 1.05 Billion USD | 5.01% |
| 1995 Q1 | 1 Billion USD | 142.14% |
| 1994 Q4 | 414.3 Million USD | -58.92% |
| 1994 Q3 | 1 Billion USD | 26.09% |
| 1994 Q2 | 799.9 Million USD | 10.71% |
| 1994 Q1 | 722.5 Million USD | 105.96% |
| 1994 FY | 414.3 Million USD | 18.1% |
| 1993 FY | 350.8 Million USD | 34.41% |
| 1993 Q1 | 718.1 Million USD | 175.13% |
| 1993 Q2 | 788.3 Million USD | 9.78% |
| 1993 Q3 | 911.4 Million USD | 15.62% |
| 1993 Q4 | 350.8 Million USD | -61.51% |
| 1992 Q2 | 885.9 Million USD | 5.01% |
| 1992 FY | 261 Million USD | -34.44% |
| 1992 Q4 | 261 Million USD | -73.62% |
| 1992 Q1 | 843.6 Million USD | 111.91% |
| 1992 Q3 | 989.3 Million USD | 11.67% |
| 1991 FY | 398.1 Million USD | 23.48% |
| 1991 Q1 | 722.1 Million USD | 123.98% |
| 1991 Q4 | 398.1 Million USD | -53.75% |
| 1991 Q3 | 860.7 Million USD | 18.59% |
| 1991 Q2 | 725.8 Million USD | 0.51% |
| 1990 FY | 322.4 Million USD | 1031.23% |
| 1990 Q1 | 500.4 Million USD | 1655.79% |
| 1990 Q3 | 1.06 Billion USD | 128.69% |
| 1990 Q4 | 322.4 Million USD | -69.86% |
| 1990 Q2 | 467.8 Million USD | -6.51% |
| 1989 FY | 28.5 Million USD | 111.91% |
| 1989 Q1 | 119.1 Million USD | 149.77% |
| 1989 Q2 | 160.3 Million USD | 34.59% |
| 1989 Q3 | 514.1 Million USD | 220.71% |
| 1989 Q4 | 28.5 Million USD | -94.46% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 94343.88% |
| Accuray Incorporated | 103.58 Million USD | -68624.538% |
| Align Technology, Inc. | -840.47 Million USD | 8570.142% |
| Elevance Health Inc. | 18.59 Billion USD | -282.86% |
| AxoGen, Inc. | 32.26 Million USD | -220531.625% |
| Boston Scientific Corporation | 8.23 Billion USD | -764.784% |
| Cardinal Health, Inc. | 476 Million USD | -14855.672% |
| Centene Corporation | 506 Million USD | -13968.972% |
| DaVita Inc. | 10.65 Billion USD | -568.329% |
| HCA Healthcare, Inc. | 40.92 Billion USD | -73.954% |
| Hologic, Inc. | 374.4 Million USD | -18914.156% |
| Humana Inc. | 5.51 Billion USD | -1189.889% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -14312.246% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -1214.081% |
| Masimo Corporation | 804 Million USD | -8754.353% |
| McKesson Corporation | 889 Million USD | -7907.762% |
| Patterson Companies, Inc. | 648.47 Million USD | -10877.859% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -1420.158% |
| ResMed Inc. | 635.57 Million USD | -11100.741% |
| Henry Schein, Inc. | 2.57 Billion USD | -2670.0% |
| Teladoc Health, Inc. | 468.6 Million USD | -15091.783% |
| Universal Health Services, Inc. | 5.24 Billion USD | -1256.707% |
| Veeva Systems Inc. | -647.71 Million USD | 11090.842% |
| Baxter International Inc. | 11.16 Billion USD | -537.551% |
| Becton, Dickinson and Company | 14.46 Billion USD | -392.215% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 2775.976% |
| Danaher Corporation | 13.49 Billion USD | -427.639% |
| Stryker Corporation | 10.02 Billion USD | -610.186% |
| Medtronic plc | 23.67 Billion USD | -200.642% |